January 2025 in “International Journal of Medicine in Developing Countries” Combining fractional photothermolysis with minoxidil is more effective for hair growth than minoxidil alone.
January 2025 in “International Journal of Scientific Research” 12.5% of women with PCOS experience moderate hair loss, highlighting the need for early detection and management.
January 2025 in “Majmaah Journal of Health Sciences” Nearly 70% of postmenopausal women in Saudi Arabia experience hair loss, often linked to early menopause, chronic diseases, family history, and stress.
January 2025 in “Clinical Cosmetic and Investigational Dermatology” Genetic testing is crucial for diagnosing rare hair loss disorders.
January 2025 in “International Journal of Trichology” Topical spironolactone and minoxidil both effectively treat female hair loss, but spironolactone has fewer side effects.
Certain combination therapies, like microneedling with minoxidil, are more effective for female-pattern hair loss than other treatments.
November 2024 in “Journal of Investigative Dermatology” Changes in scalp bacteria are linked to female hair loss, suggesting new treatment options.
October 2024 in “JEADV Clinical Practice” UK dermatologists commonly use corticosteroids and minoxidil to treat hair loss conditions.
October 2024 in “Clinical and Experimental Dermatology” The combination treatment didn't work better than minoxidil alone and caused more menstrual issues.
Combining Nanofat with PRP is a safe and effective treatment for female pattern hair loss.
October 2024 in “Skin Research and Technology” Extracorporeal shock waves significantly improve hair growth in women with female pattern hair loss.
September 2024 in “Indian Journal of Dermatology Venereology and Leprology” Mesotherapy with bicalutamide has limited effectiveness for female hair loss.
September 2024 in “Egyptian Journal of Dermatology and Venerology” Low-energy fractional CO2 laser therapy significantly improves hair regrowth in women with female-pattern hair loss.
September 2024 in “Journal of the American Academy of Dermatology” Using gratitude journals can improve perceived hair loss and quality of life in women.
September 2024 in “Journal of the American Academy of Dermatology” Estetrol (E4) may help treat female pattern hair loss by prolonging hair growth.
September 2024 in “Journal of the American Academy of Dermatology” Smoking can cause and worsen male pattern hair loss.
August 2024 in “IAHS Medical Journal” Low vitamin D and ferritin levels are linked to female hair loss.
Women with female pattern hair loss may have a higher risk of metabolic syndrome.
August 2024 in “Indian Journal of Dermatology Venereology and Leprology” The book provides comprehensive treatment strategies for female hair loss.
August 2024 in “Skin Research and Technology” Low-dose oral minoxidil can help increase hair growth in women with hair loss.
Certain genes may influence hair loss differently in men and women.
July 2024 in “Clinical and Experimental Dermatology” Hair loss patterns in Asian and Black women are unique and may affect treatment.
July 2024 in “Journal of Investigative Dermatology” Most women continued using oral minoxidil for hair loss despite mild to moderate side effects.
June 2024 in “Current Developments in Nutrition” Omega-3 fatty acids may not help and could harm hair loss improvement in middle-aged or elderly men.
June 2024 in “Skin Research and Technology” Severe male pattern hair loss is linked to lower hair density in the back of the head.
June 2024 in “Journal of Cosmetic Dermatology” Hair transplants are better for severe hair loss, while scalp micropigmentation suits those with denser hair.
June 2024 in “Journal of cosmetic dermatology” The document corrects errors in a table about hair loss in women.
June 2024 in “Archives of Dermatological Research” SFRP2 and PTGDS may be key factors in female hair loss.
June 2024 in “Sohag Medical Journal” Vitamin D is linked to hair health, but more research is needed for its use in treating female hair loss.
10% minoxidil improves frontal hair count more than 5% but has more side effects.